Abbott Laboratories
US ˙ NYSE ˙ US0028241000

SecurityABT / Abbott Laboratories
InstitutionStock Portfolio - Stock Portfolio
Latest Disclosed Ownership77,862 shares
Latest Disclosed Value $ 10,590,010
Stock Portfolio - Stock Portfolio reports 8.10% decrease in ownership of ABT / Abbott Laboratories

On August 25, 2025 - Stock Portfolio - Stock Portfolio filed a NPORT-P form disclosing ownership of 77,862 shares of Abbott Laboratories (US:ABT) valued at $10,590,011 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 84,723 shares of Abbott Laboratories. This represents a change in shares of -8.10% during the quarter. The current value of the position is $7,090,892 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-25 2025-06-30 NP Abbott Laboratories EC US0028241000 77,862 -6,861 -8.10 10,590 -5.77 1.3786
2025-05-28 2025-03-31 NP Abbott Laboratories EC US0028241000 84,723 19,383 29.66 11,239 52.07 1.6280
2025-02-19 2024-12-31 NP Abbott Laboratories EC US0028241000 65,340 65,340 7,391 0.9894
2021-05-28 2021-03-31 NP Abbott Laboratories EC US0028241000 0 -144,300 -100.00 0 -100.00
2021-02-16 2020-12-31 NP Abbott Laboratories EC US0028241000 144,300 -1,200 -0.82 15,799 -0.22 1.9640
2020-11-25 2020-09-30 NP Abbott Laboratories EC US0028241000 145,500 9,400 6.91 15,835 27.25 2.1882
2020-08-24 2020-06-30 NP Abbott Laboratories EC US0028241000 136,100 -4,300 -3.06 12,444 12.32 1.8631
2020-05-29 2020-03-31 NP Abbott Laboratories EC US0028241000 140,400 57,200 68.75 11,079 53.31 2.0196
2020-02-24 2019-12-31 NP Abbott Laboratories EC 002824100 83,200 6,200 8.05 7,227 12.17 1.0572
2019-11-27 2019-09-30 NP Abbott Laboratories EC US0028241000 77,000 77,000 6,443 0.9924
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.